Literature DB >> 18312718

Lysosomal cholesterol accumulation inhibits subsequent hydrolysis of lipoprotein cholesteryl ester.

W Gray Jerome1, Brian E Cox, Evelyn E Griffin, Jody C Ullery.   

Abstract

Human macrophages incubated for prolonged periods with mildly oxidized LDL (oxLDL) or cholesteryl ester-rich lipid dispersions (DISP) accumulate free and esterified cholesterol within large, swollen lysosomes similar to those in foam cells of atherosclerosis. The cholesteryl ester (CE) accumulation is, in part, the result of inhibition of lysosomal hydrolysis due to increased lysosomal pH mediated by excessive lysosomal free cholesterol (FC). To determine if the inhibition of hydrolysis was long lived and further define the extent of the lysosomal defect, we incubated THP-1 macrophages with oxLDL or DISP to produce lysosome sterol engorgement and then chased with acetylated LDL (acLDL). Unlike oxLDL or DISP, CE from acLDL normally is hydrolyzed rapidly. Three days of incubation with oxLDL or DISP produced an excess of CE in lipid-engorged lysosomes, indicative of inhibition. After prolonged oxLDL or DISP pretreatment, subsequent hydrolysis of acLDL CE was inhibited. Coincident with the inhibition, the lipid-engorged lysosomes failed to maintain an acidic pH during both the initial pretreatment and subsequent acLDL incubation. This indicates that the alterations in lysosomes were general, long lived, and affected subsequent lipoprotein metabolism. This same phenomenon, occurring within atherosclerotic foam cells, could significantly affect lesion progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18312718      PMCID: PMC2837357          DOI: 10.1017/S1431927608080069

Source DB:  PubMed          Journal:  Microsc Microanal        ISSN: 1431-9276            Impact factor:   4.127


  49 in total

1.  Fluorescence lifetime characterization of novel low-pH probes.

Authors:  H J Lin; P Herman; J S Kang; J R Lakowicz
Journal:  Anal Biochem       Date:  2001-07-15       Impact factor: 3.365

2.  Regulation of organelle acidity.

Authors:  M Grabe; G Oster
Journal:  J Gen Physiol       Date:  2001-04       Impact factor: 4.086

3.  Uptake and trafficking of mildly oxidized LDL and acetylated LDL in THP-1 cells does not explain the differences in lysosomal metabolism of these two lipoproteins.

Authors:  Patricia G Yancey; Stacia Miles; Jennifer Schwegel; W Gray Jerome
Journal:  Microsc Microanal       Date:  2002-04       Impact factor: 4.127

4.  Lysosomal cholesterol derived from mildly oxidized low density lipoprotein is resistant to efflux.

Authors:  P G Yancey; W G Jerome
Journal:  J Lipid Res       Date:  2001-03       Impact factor: 5.922

Review 5.  Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis.

Authors:  L L Rudel; R G Lee; T L Cockman
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

6.  Effects of cellular cholesterol loading on macrophage foam cell lysosome acidification.

Authors:  Brian E Cox; Evelyn E Griffin; Jody C Ullery; W Gray Jerome
Journal:  J Lipid Res       Date:  2007-02-16       Impact factor: 5.922

7.  Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally.

Authors:  B S Dhaliwal; U P Steinbrecher
Journal:  J Lipid Res       Date:  2000-10       Impact factor: 5.922

8.  Aggregated LDL and lipid dispersions induce lysosomal cholesteryl ester accumulation in macrophage foam cells.

Authors:  Evelyn E Griffin; Jody C Ullery; Brian E Cox; W Gray Jerome
Journal:  J Lipid Res       Date:  2005-07-16       Impact factor: 5.922

Review 9.  The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism.

Authors:  W Gray Jerome; Patricia G Yancey
Journal:  Microsc Microanal       Date:  2003-02       Impact factor: 4.127

10.  Phospholipids in oxidized low density lipoproteins perturb the ability of macrophages to degrade internalized macromolecules and reduce intracellular cathepsin B activity.

Authors:  June O'Neil; George Hoppe; Henry F Hoff
Journal:  Atherosclerosis       Date:  2003-08       Impact factor: 5.162

View more
  19 in total

1.  Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.

Authors:  Rabea Asleh; John Ward; Nina S Levy; Shady Safuri; Doron Aronson; Andrew P Levy
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

2.  LIPA Variants in Genome-Wide Association Studies of Coronary Artery Diseases: Loss-of-Function or Gain-of-Function?

Authors:  Hanrui Zhang; Muredach P Reilly
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06       Impact factor: 8.311

3.  Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis.

Authors:  Michelle J Ormseth; Patricia G Yancey; Suguru Yamamoto; Annette M Oeser; Tebeb Gebretsadik; Ayumi Shintani; MacRae F Linton; Sergio Fazio; Sean S Davies; L Jackson Roberts; Kasey C Vickers; Paolo Raggi; Valentina Kon; C Michael Stein
Journal:  IJC Metab Endocr       Date:  2016-08-28

4.  Dysfunctional high-density lipoproteins in children with chronic kidney disease.

Authors:  Ryohei Kaseda; Kathy Jabs; Tracy E Hunley; Deborah Jones; Aihua Bian; Ryan M Allen; Kasey C Vickers; Patricia G Yancey; MacRae F Linton; Sergio Fazio; Valentina Kon
Journal:  Metabolism       Date:  2014-10-25       Impact factor: 8.694

Review 5.  Lysosomal acid lipase and lipid metabolism: new mechanisms, new questions, and new therapies.

Authors:  Hanrui Zhang
Journal:  Curr Opin Lipidol       Date:  2018-06       Impact factor: 4.776

6.  Angiotensin receptor blocker vs ACE inhibitor effects on HDL functionality in patients on maintenance hemodialysis.

Authors:  R Kaseda; Y Tsuchida; J L Gamboa; J Zhong; L Zhang; H Yang; A Dikalova; A Bian; S Davies; A F Fogo; M F Linton; N J Brown; T A Ikizler; V Kon
Journal:  Nutr Metab Cardiovasc Dis       Date:  2018-03-08       Impact factor: 4.222

7.  Triglyceride alters lysosomal cholesterol ester metabolism in cholesteryl ester-laden macrophage foam cells.

Authors:  Jody C Ullery-Ricewick; Brian E Cox; Evelyn E Griffin; W Gray Jerome
Journal:  J Lipid Res       Date:  2009-05-21       Impact factor: 5.922

8.  Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages.

Authors:  Shann S Yu; Cheryl M Lau; Susan N Thomas; W Gray Jerome; David J Maron; James H Dickerson; Jeffrey A Hubbell; Todd D Giorgio
Journal:  Int J Nanomedicine       Date:  2012-02-15

9.  Kidney injury-mediated disruption of intestinal lymphatics involves dicarbonyl-modified lipoproteins.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valery Yermalitsky; Elaine L Shelton; Tadashi Otsuka; Carrie B Wiese; Linda S May-Zhang; Babak Banan; Naji Abumrad; Jiansheng Huang; Ashley B Cavnar; Annet Kirabo; Patricia G Yancey; Agnes B Fogo; Kasey C Vickers; MacRae F Linton; Sean S Davies; Valentina Kon
Journal:  Kidney Int       Date:  2021-06-05       Impact factor: 18.998

10.  Whole-cell analysis of low-density lipoprotein uptake by macrophages using STEM tomography.

Authors:  Jean-Pierre Baudoin; W Gray Jerome; Christian Kübel; Niels de Jonge
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.